Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice
- 1 June 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 115 (6), 1229-1232
- https://doi.org/10.1016/0002-8703(88)90013-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prevention of viral myocarditis with recombinant human leukocyte interferon α A/D in a murine modelJournal of the American College of Cardiology, 1987
- Protective Effect of Interferon on Infections with Hand, Foot, and Mouth Disease Virus in Newborn MiceThe Journal of Infectious Diseases, 1986
- Treatment of viral myocarditis with ribavirin in an animal preparation.Circulation, 1985
- Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferonJournal of Molecular and Cellular Cardiology, 1985
- Ameliorating Effect of IFN-β and Anti-IFN-β on Coxsackievirus B3-Induced Myocarditis in MiceJournal of Interferon Research, 1985
- An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.Circulation, 1982
- Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of miceInfection and Immunity, 1982
- Coxsackie virus B3 perimyocarditis in BALB/c mice: Experimental model of chronic perimyocarditis in the right ventricleThe Journal of Pathology, 1980